Aspen Aerogels/$ASPN
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Aspen Aerogels
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.
- Ticker
- $ASPN
- Sector
- Materials
- Primary listing
- NYSE
- Employees
- 854
- Headquarters
- Northborough, United States
- Website
- www.aerogel.com
Aspen Aerogels Metrics
BasicAdvanced
$498M
-
-$1.57
3.07
-
Price and volume
Market cap
$498M
Beta
3.07
52-week high
$8.10
52-week low
$2.30
Average daily volume
1.1M
Financial strength
Current ratio
2.105
Quick ratio
1.708
Long term debt to equity
0.449
Total debt to equity
0.629
Interest coverage (TTM)
-4.21%
Profitability
EBITDA (TTM)
-27.025
Gross margin (TTM)
22.28%
Net profit margin (TTM)
-60.81%
Operating margin (TTM)
-22.23%
Effective tax rate (TTM)
-0.67%
Revenue per employee (TTM)
$250,000
Management effectiveness
Return on assets (TTM)
-6.72%
Return on equity (TTM)
-53.16%
Valuation
Price to revenue (TTM)
2.316
Price to book
2.7
Price to tangible book (TTM)
2.7
Price to free cash flow (TTM)
-32.999
Free cash flow yield (TTM)
-3.03%
Free cash flow per share (TTM)
-0.182
Growth
Revenue change (TTM)
-39.28%
Earnings per share change (TTM)
-57.82%
3-year revenue growth (CAGR)
0.02%
10-year revenue growth (CAGR)
5.33%
3-year earnings per share growth (CAGR)
22.56%
10-year earnings per share growth (CAGR)
22.82%
What the Analysts think about Aspen Aerogels
Analyst ratings (Buy, Hold, Sell) for Aspen Aerogels stock.
Analyst projections of the future price of Aspen Aerogels stock.
Bulls say / Bears say
Q3 revenue rose 17% year on year to $85.2 million, while adjusted EBITDA more than trebled to $19.8 million. That points to meaningful operating leverage as volumes recover, even with disruption costs still weighing on reported results. (Aspen Aerogels)
European thermal-barrier sales hit a quarterly record of $8 million, with seven OEMs across eight programmes. Aspen targets $50 million to $60 million of European revenue in 2027, which could reduce reliance on its established North American business. (Aspen Aerogels)
Energy Industrial revenue grew 64% year on year to $39.9 million in Q3, and Aspen has won a data-centre order and a project for 2027. Initial battery-storage sales also give the company new markets beyond its core industrial insulation business. (Aspen Aerogels)
Despite the Q3 rebound, revenue for the first nine months of 2026 fell 25% year on year, and Thermal Barrier sales fell 40%. The filing links the weakness to lower EV volumes and says a customer settlement contributed $13.2 million of recognised revenue, so underlying demand remains a concern. (SEC)
The East Providence incident added $15.1 million of costs in Q3, and full restoration is not expected until the first half of 2027. Further delays could keep costs high or constrain Aspen’s ability to meet customer demand. (Aspen Aerogels, SEC)
Aspen remains exposed to General Motors in Thermal Barriers: its contracts require no minimum purchase volume, and GM can terminate them at any time. That leaves sales vulnerable to changes in one customer’s production plans. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 9 Nov 2026.
Aspen Aerogels Financial Performance
Revenues and expenses
Aspen Aerogels Earnings Performance
Company profitability
Upcoming events
No upcoming events
Aspen Aerogels News
AllArticlesVideos
Funds containing Aspen Aerogels
Fund name | Fund size | $ASPN weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | $4.7B | 0.02% |
SPDR Russell 2000 US Small Cap£R2SC | $4.7B | 0.02% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.